Cargando…

Nutritional Approach Targeting Gut Microbiota in NAFLD—To Date

Non-alcoholic fatty liver disease (NAFLD) is a significant clinical and epidemiological problem that affects around 25% of the adult global population. A large body of clinical evidence highlights that NAFLD is associated with increased liver-related morbidity and mortality and an increased risk of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Moszak, Małgorzata, Szulińska, Monika, Walczak-Gałęzewska, Marta, Bogdański, Paweł
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7916007/ https://www.ncbi.nlm.nih.gov/pubmed/33567710 http://dx.doi.org/10.3390/ijerph18041616

Ejemplares similares

You Are What You Eat—The Relationship between Diet, Microbiota, and Metabolic Disorders—A Review
por: Moszak, Małgorzata, et al.
Publicado: (2020)

Conservative management of acute calculous cholecystitis complicated by pancreatitis in an elderly woman: A case report
por: Walczak-Galezewska, Marta K., et al.
Publicado: (2018)

The effect of nebivolol and ramipril on selected biochemical parameters, arterial stiffness, and circadian profile of blood pressure in young men with primary hypertension: A 12-week prospective randomized, open-label study trial
por: Walczak-Gałęzewska, Marta, et al.
Publicado: (2018)

The Role of Magnesium in the Pathogenesis of Metabolic Disorders
por: Pelczyńska, Marta, et al.
Publicado: (2022)

The Preventive Mechanisms of Bioactive Food Compounds against Obesity-Induced Inflammation
por: Pelczyńska, Marta, et al.
Publicado: (2023)

Berberine in Non-Alcoholic Fatty Liver Disease—A Review
por: Koperska, Anna, et al.
Publicado: (2022)

The Effect of Artificial Sweeteners Use on Sweet Taste Perception and Weight Loss Efficacy: A Review
por: Wilk, Klara, et al.
Publicado: (2022)

Probiotics in the Prevention and Treatment of Gestational Diabetes Mellitus (GDM): A Review
por: Kamińska, Klaudia, et al.
Publicado: (2022)

Analysis of correlations between gut microbiota, stool short chain fatty acids, calprotectin and cardiometabolic risk factors in postmenopausal women with obesity: a cross-sectional study
por: Łoniewski, Igor, et al.
Publicado: (2022)

Gut Microbiota and Lifestyle Interventions in NAFLD
por: Houghton, David, et al.
Publicado: (2016)

Iron Excess Disturbs Metabolic Status and Relative Gonad Mass in Rats on High Fat, Fructose, and Salt Diets
por: Suliburska, Joanna, et al.
Publicado: (2012)

Treatment With Multi-Species Probiotics Changes the Functions, Not the Composition of Gut Microbiota in Postmenopausal Women With Obesity: A Randomized, Double-Blind, Placebo-Controlled Study
por: Kaczmarczyk, Mariusz, et al.
Publicado: (2022)

Comparison of the effect of rapeseed oil or amaranth seed oil supplementation on weight loss, body composition, and changes in the metabolic profile of obese patients following 3-week body mass reduction program: a randomized clinical trial
por: Moszak, Małgorzata, et al.
Publicado: (2020)

Gut Microbiota: Association with NAFLD and Metabolic Disturbances
por: Lau, E., et al.
Publicado: (2015)

Gut Microbiota Metabolites in NAFLD Pathogenesis and Therapeutic Implications
por: Chen, Jiezhong, et al.
Publicado: (2020)

Gut Microbiota and NAFLD: Pathogenetic Mechanisms, Microbiota Signatures, and Therapeutic Interventions
por: Hrncir, Tomas, et al.
Publicado: (2021)

Short-Term Effects of Sibutramine on Mineral Status and Selected Biochemical Parameters in Obese Women
por: Suliburska, Joanna, et al.
Publicado: (2012)

Effects of Green Tea Supplementation on Elements, Total Antioxidants, Lipids, and Glucose Values in the Serum of Obese Patients
por: Suliburska, Joanna, et al.
Publicado: (2012)

Association of Serum Vaspin Concentration with Metabolic Disorders in Obese Individuals
por: Pilarski, Łukasz, et al.
Publicado: (2023)

Advances in the Involvement of Gut Microbiota in Pathophysiology of NAFLD
por: Jiang, Xiaofan, et al.
Publicado: (2020)

Nutritional Interventions Targeting Gut Microbiota during Cancer Therapies
por: Rinninella, Emanuele, et al.
Publicado: (2021)

Changes in mineral status are associated with improvements in insulin sensitivity in obese patients following l-arginine supplementation
por: Suliburska, Joanna, et al.
Publicado: (2013)

Dose-Dependent Effects of Multispecies Probiotic Supplementation on the Lipopolysaccharide (LPS) Level and Cardiometabolic Profile in Obese Postmenopausal Women: A 12-Week Randomized Clinical Trial
por: Szulińska, Monika, et al.
Publicado: (2018)

The Multispecies Probiotic Effectively Reduces Homocysteine Concentration in Obese Women: A Randomized Double-Blind Placebo-Controlled Study
por: Majewska, Karolina, et al.
Publicado: (2020)

Current Research on the Pathogenesis of NAFLD/NASH and the Gut–Liver Axis: Gut Microbiota, Dysbiosis, and Leaky-Gut Syndrome
por: Kobayashi, Takashi, et al.
Publicado: (2022)

Thioredoxin/Glutaredoxin Systems and Gut Microbiota in NAFLD: Interplay, Mechanism, and Therapeutical Potential
por: Zhu, Minghui, et al.
Publicado: (2023)

Effects of green tea supplementation on inflammation markers, antioxidant status and blood pressure in NaCl-induced hypertensive rat model
por: Szulińska, Monika, et al.
Publicado: (2017)

Influence of Gluten-Free Diet on Gut Microbiota Composition in Patients with Coeliac Disease: A Systematic Review
por: Kaliciak, Iwona, et al.
Publicado: (2022)

Diuretics, Ca-Antagonists, and Angiotensin-Converting Enzyme Inhibitors Affect Zinc Status in Hypertensive Patients on Monotherapy: A Randomized Trial
por: Suliburska, Joanna, et al.
Publicado: (2018)

The Relation between Resistin (−420C/G) Single Nucleotide Variant, Resistin Serum Concentration, Carbohydrate, and Lipid Parameters and Fried Food Taste Preference in Patients with Hypertriglyceridemia
por: Miller-Kasprzak, Ewa, et al.
Publicado: (2022)

The Role of Gut–Liver Axis in Gut Microbiome Dysbiosis Associated NAFLD and NAFLD-HCC
por: Song, Qian, et al.
Publicado: (2022)

Nutrition, gut microbiota and immunity: Therapeutic targets for IBD
por: Puri, A.S.
Publicado: (2016)

Meta-Omic Platforms to Assist in the Understanding of NAFLD Gut Microbiota Alterations: Tools and Applications
por: Del Chierico, Federica, et al.
Publicado: (2014)

Gut Microbiota and Time-Restricted Feeding/Eating: A Targeted Biomarker and Approach in Precision Nutrition
por: Zeb, Falak, et al.
Publicado: (2023)

CONSORT-Characteristics and metabolic phenotype of gut microbiota in NAFLD patients
por: Ge, Haize, et al.
Publicado: (2022)

Parenteral Nutrition-Associated Liver Disease: The Role of the Gut Microbiota
por: Cahova, Monika, et al.
Publicado: (2017)

Multispecies Probiotic Supplementation Favorably Affects Vascular Function and Reduces Arterial Stiffness in Obese Postmenopausal Women—A 12-Week Placebo-Controlled and Randomized Clinical Study
por: Szulińska, Monika, et al.
Publicado: (2018)

Microbiota, Fiber, and NAFLD: Is There Any Connection?
por: Pérez-Montes de Oca, Alejandra, et al.
Publicado: (2020)

Fecal Microbiota Transplantation in NAFLD Treatment
por: Abenavoli, Ludovico, et al.
Publicado: (2022)

Diet and Gut Microbiota Interaction-Derived Metabolites and Intrahepatic Immune Response in NAFLD Development and Treatment
por: Yang, Ming, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_jfna2qsr7ba2pbc8q660o262sn